The antihyperglycemic therapeutic class will continue to be a major contributor to prescription drug trends in 2011 and beyond.
January/February 2011
Generic drug discount programs, which differ across large chain pharmacies, may result in significant savings for managed care organizations.
Therapeutic interchange from donepezil to galantamine extended-release: a 3-month analysis.
The continuing education article reviews diabetes quality improvement efforts and the potential for expanding the role of pharmacists as clinical care providers.
Erlotinib may confer an economic advantage for payers over docetaxel and pemetrexed for second-line treatment of lung cancer because of lower costs.
The Phaseal closed system drug transfer device provides a mechanical barrier to the entry of contaminants into sterile solutions for up to 168 hours.
The large number of medications to treat neurologic conditions that are in the pipeline will require assessment of safety, efficacy, and cost-effectiveness.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Grants Interchangeability Designation to Denosumab Biosimilars Stoboclo and Osenvelt
2
Denosumab Biosimilars Conexxence and Bomyntra Receive Interchangeability Designation
3
Because Ned Said: America’s Growing Pharmacy Deserts Are Leaving Patients High and Dry
4
Meeting Patients Where They Are: How Pharmacists Are Helping People Stay on Track With Schizophrenia Treatment
5
